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Abstract: Two new neutral fac-[Re(CO)3(phen)L] compounds (1,2), with phen = 1,10-phenanthroline
and L = O2C(CH2)5CH3 or O2C(CH2)4C≡CH, were synthetized in one-pot procedures from
fac-[Re(CO)3(phen)Cl] and the corresponding carboxylic acids, and were fully characterized by IR and
UV-Vis absorption spectroscopy, 1H- and 13C-NMR, mass spectrometry and X-ray crystallography.
The compounds, which display orange luminescence, were used as probes for living cancer HeLa cell
staining. Confocal microscopy revealed accumulation of both dyes in mitochondria. To investigate
the mechanism of mitochondrial staining, a new non-emissive compound, fac-[Re(CO)3(phen)L],
with L = O2C(CH2)3((C5H5)Fe(C5H4), i.e., containing a ferrocenyl moiety, was synthetized and
characterized (3). 3 shows the same mitochondrial accumulation pattern as 1 and 2. Emission
of 3 can only be possible when ferrocene-containing ligand dissociates from the metal center to
produce a species containing the luminescent fac[Re(CO)3(phen)]+ core. The release of ligands from
the Re center was verified in vitro through the conjugation with model proteins. These findings
suggest that the mitochondria accumulation of compounds 1–3 is due to the formation of luminescent
fac-[Re(CO)3(phen)]+ products, which react with cellular matrix molecules giving secondary products
and are uptaken into the negatively charged mitochondrial membranes. Thus, reported compounds
feature a rare dissociation-driven mechanism of action with great potential for biological applications.
Keywords: bioorganometallics; rhenium complexes; ferrocene; confocal microscopy; luminescence;
mitochondria staining; phototoxicity
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1. Introduction
Luminescent transition metal complexes have been extensively used in organic light-emitting
diodes (OLEDs) [1], as optical sensors [2], and in solar cell materials [3]. Over the last decade,
this class of materials has attracted an increased attention as luminescent [4–13] and vibrational-
luminescent [14] probes for bioimaging. In particular, fac-[Re(CO)3(N∧N)L] (N∧N = aromatic
diimine and L = ancillary ligand) complexes have been investigated for bioimaging applications [4,13].
Upon photoexcitation, fac-[Re(CO)3(N∧N)L] complexes display green to orange phosphorescence
stemming from triplet metal-to-ligand charge-transfer (3MLCT) states [15–18]. The emission occurs at
much longer wavelengths and with distinctly longer decay times than the cell autofluorescence. Both
effects are beneficial for bioimaging applications [5]. Studies on luminescent rhenium complexes have
also had a great impact on development of 99mTc and 186,188Re containing radiopharmaceuticals [13,19].
A literature survey shows that four basic classes of luminescent bioprobes with fac-{Re(CO)3} cores can
be identified (Figure 1A–D).
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Most of the research has been focused on cationic complexes (classes A and B in Figure 1) which 
preferably stain mitochondria [20–23]. Relevant examples of such compounds comprise cationic A1 [20] 
and A2 [21] species which stain mitochondria of MCF-7 cells, and dication A3, which accumulates in 
endoplasmatic retictulum (ER), Golgi apparatus and mitochondria [22]. Staining mechanisms 
significantly depend on many factors, e.g. probe concentration or ligand reactivity [20,23,24]. For 
example, it has been found that compound A1 covalently binds to thiol-rich mitochondrial 
components that allow for efficient accumulation [20]. A remarkable example of class B compounds is the 
naphthalimide derivative B1 which shows a concentration-dependent pathway of accumulation in 
cellular compartments. At low concentrations, B1 stains smooth endoplasmic membranes of 
osteoarthritic cells, while at higher concentrations it rapidly binds to mitochondria membranes [23]. 
Neutral complexes (classes C and D in Figure 1) have been found to accumulate in nucleus and 
perinuclear compartments of the cell [24,25]. Dirhenium piridazine complex C1 stain the cytoplasm 
Figure 1. Basic structures of luminescent fac-{Re(CO)3} complexes for cell bioimaging and their
examples. Four basic classes of luminescent bioprobes with fac-{Re(CO)3} cores (A–D).
Most of the research has been focused on cationic complexes (classes A and B in Figure 1) which
preferably stain mitochondria [20–23]. Relevant examples of such compounds comprise cationic A1 [20]
and A2 [21] species which stain mitochondria of MCF-7 cells, and dication A3, which accumulates
in endoplasmatic retictulum (ER), Golgi apparatus and mitochondria [22]. Staining mechanisms
significantly depend on many factors, e.g. probe concentration or ligand reactivity [20,23,24].
For example, it has been found that compound A1 covalently binds to thiol-rich mitochondrial
components that allow for efficient accumulation [20]. A remarkable example of class B compounds is
the naphthalimide derivative B1 which shows a concentration-dependent pathway of accumulation
in cellular compartments. At low concentrations, B1 stains smooth endoplasmic membranes of
osteoarthritic cells, while at higher concentrations it rapidly binds to mitochondria membranes [23].
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Neutral complexes (classes C and D in Figure 1) have been found to accumulate in nucleus and
perinuclear compartments of the cell [24,25]. Dirhenium piridazine complex C1 stain the cytoplasm
and nucleus [25], and compounds D1–3 stain the perinuclear region of MDA-MB-231 cells [24]. It has
been observed that the cellular uptake of D1–3 compounds increases as the alkyl chain length of the
ligand increases [24]. Moreover, for several compounds photocytotoxic and/or cytotoxic activity has
been observed [26–37].
Herein we report the synthesis and characterization, including X-ray structure analysis, of three
new fac-[Re(CO)3(1,10-phenantroline)L] complexes, hereafter called 1–3, with different ancillary
ligands: L = heptanoic acid (1), hept-6-ynoic acid (2), and 4-(1-ferrocenyl)-butanoic acid (3), respectively.
Complexes 1 and 2 are luminescent, whereas complex 3, comprising of a quenching ferrocenyl moiety,
does not [38]. Accumulation of 1–3 in mitochondria is observed for HeLa cells via confocal microscopy.
Upon prolonged laser irradiation, 2 displays photocytotoxic activity. Comparative analysis of the data
collected for the three compounds and results obtained for the adducts of 1 and 3 with model proteins
enables us to propose a mechanism explaining the molecular basis of the mitochondrial accumulation
of 1–3.
2. Results and Discussion
2.1. Synthesis of Complexes 1–3
A literature survey shows that fac-[Re(CO)3(phen)L], where phen = 1,10-phenanthroline and
L = carboxylate ligand, complexes can be prepared by: (i) reaction of fac-[Re(CO)3(phen)X] (with X = Cl
or Br) precursor with a silver salt of respective carboxylic acid or fac-[Re(CO)3(phen)CF3SO3]
precursor with carboxylic acid [39–41]; (ii) reaction of fac-[Re(CO)3(phen)(OH)] complex with ketene or
lactide [42]; and (iii) reaction of an aqua [Re(OH2)3(CO)3]+ complex with a carboxylate-phenantroline
ligand [43]. Our approach toward the synthesis of complexes 1, 2, and 3 was carried out according to
Scheme 1.
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and UV-Vis absorption spectroscopy, mass spectrometry (MS), and elemental analysis. All analytical 
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display three very strong ν(C≡O) bands at 2027–1866 cm−1, strong ν(C=O) bands at 1622–1606 cm−1 and 
solely in the case of alkyne complex 2, a weak ν(C≡C) band at 2119 cm−1. The 1H NMR spectra of the 
three products are presented in Figures S1–S3 (SI). In the 1H-NMR spectrum of complex 2, a 
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The molecular structures of 1–3 were determined by single-crystal X-ray analysis. Crystals of 1 
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Scheme 1. Synthesis of complexes 1–3.
We found that the fac-[Re(CO)3(phen)Cl] complex [44] readily reacts with carboxylic acids in
THF in the presence of trimethylamine and silver trifluoromethanesulfonate at 70 ◦C to afford
products 1, 2 and 3 in a 95%, 65%, and 48% yield, respectively. The mechanism most probably
involves a reaction of the carboxylic anion L− and fac-[Re(CO)3(phen)]+ cation, generated in situ,
yielding the target complex. This approach represents a simple one-pot procedure for obtaining
carboxylato-Re(CO)3(N-N) complexes. Compounds 1 and 2 are yellow air-stable soli s, whereas
complex 3 i an orang air-stable solid. The products were characterized by 1H-NMR, 13C-NMR, IR
and UV-Vis absorption spectroscopy, mass spectrometry (MS), and elemental analysis. All analytical
data confirmed the proposed structures. The IR spectra of complexes 1–3 in potassium bromide display
three very strong ν(C≡O) bands at 2027–1866 cm−1, strong ν(C=O) bands at 1622–1606 cm−1 and solely
in the case of alkyne complex 2, a weak ν(C≡C) band at 2119 cm−1. The 1H-NMR spectra of the three
products are present d in Figures S1–S3 (SI). In the 1H-NMR spectrum of complex 2, a characteristic
alkyne signal at δ = 2.56 ppm is observed.
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2.2. Single-Crystal X-ray Structural Analysis of Complexes 1–3
The molecular structures of 1–3 were determined by single-crystal X-ray analysis. Crystals of 1
and 3 that were suitable for X-ray diffraction analysis were obtained from dimethyl sulfoxide-water
mixture, whereas crystals of 2 were obtained by slow diffusion of n-pentane into a dichloromethane
solution of 2. It turned out that the investigated compounds crystallize in the P21/n (1 and 2) or
P21 (3) space group of the monoclinic crystal system with one (1 and 2) or two molecules (3) of the
given compound in the asymmetric unit, respectively. The Oak Ridge thermal ellipsoid plot (ORTEP)
drawing of 1, 2, and 3 is shown with atom numbering in Figure 2. Details of crystallographic data and
refinement parameters are summarized in Table S1. Geometrical parameters of 1–3 are presented in
Table 1 and in Tables S2–S10 of Supplementary Materials.
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able 1. Selected bond distances (Å) and angles (◦) of 1–3 (Cpsub s stit te ri ).
1 2 3A 3B
Bond distances
C1-O1 1.154(2) 1.151(5) 1.164(4) 1.174(5)
C2-O2 1.155(2) 1.152(4) 1.160(4) 1.167(5)
C3-O3 1.164(2) 1.1 1.157(4) 1.152(4)
Re1-C1 1.922(2) 1.924(4) 1.903(4) 1.901(4)
Re1-C2 1.923(2) 1.926(3) 1.917(3) 1.911(4)
Re1-C3 1.900(2) 1.903(3) 1.910(3) 1.919(4)
Re1-N1 2.176(2) 2.173(3) 2.177(3) 2.181(3)
Re1-N2 2.184(2) 2.185(3) 2.175(3) 2.180(3)
Re1-O4 2.1 2(2) 2.146 2 2.125(2) 2.129(2)
Fe-mid point (Cpsub) - - 1.654(2) 1.649(2)
Fe-mid point (Cp) - - 1.651(2) 1.651(2)
bond angles
O4-C16-O5 125.33(16) 125.0(3) 125.7(3) 125.5(3)
O4-Re1-N1 81.42(5) 80.83(9) 82.33(9) 79.74(10)
O4-Re1-C1 95.58(7) 94.89(13) 96.39(12) 98.50(13)
O4-Re1-C3 174.96(6) 174.70(12) 174.35(12) 173.61(12)
All analyzed complexes exhibit typical distorted octahedral geometry with a fac-{Re(CO)3}
arrangement and the axially oriented carboxylic ligand [42,45]. The hydrocarbon chain of the ligand in
1 is disordered over two positions with the site occupancy factors of 0.679(4) and 0.321(4). The whole
lig d is strongly d flected relativ to the phenantroline unit (Figure 2 (left)). In the case of 2
3, the carb xylic ligands are directed towards the plane of the phenantroline ring system (Figure 2
(middle) (right)). The abov -m n oned differences in th spa ial arrangement result from the
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packing effects of individual molecules in the crystal lattice. The length of the axial Re–O bond in 1
and 2 is 2.143(1) and 2.146(2) Å respectively, and is comparable to the value that is observed in similar
rhenium complexes [42,45]. In the case of 3, the Re–O bond length is slightly shorter and its value is
2.125(2) and 2.129(2) Å for the two molecules in the asymmetric unit (molecule A and B hereafter),
respectively. X-ray diffraction confirmed the O-coordination mode of hept-6-ynoic acid ligand in 2.
The C(21)-C(22) terminal triple bond length is 1.174(6) Å. The iron atom in ferrocenyl groups of 3
is symmetrically displaced between the cyclopentadienyl ligands. For example, in molecule 3A the
Fe-Mp distances (Mp corresponds to the mid-point of the respective cyclopentadienyl ring) are 1.654(2)
and 1.651(2) Å for the substituted and unsubstituted cyclopentadienyl ring, respectively. Similar
results are found in molecule B. Ferrocenyl groups present in the asymmetric unit of 3 deviate from
the eclipsed conformation by ϕ = 6◦ and 10◦ for the molecules A and B, respectively.
2.3. Photophysical Characterization
Electronic absorption spectra of complexes 1–3 are dominated by the features of the
fac[Re(CO)3(phen)] core. In particular, as it is shown in Figure 3 and Table 2, an intense ligand
centered (1LC) pi-pi* transition of the phenanthroline ligand, with a maximum at 262 nm, is observed.
The low-energy part of the spectra is dominated by a moderately strong broad metal-to-ligand
charge-transfer (1MLCT) d(Re)-pi*(phen) electronic transition centered at 375 nm [44,46]. The relatively
very weak metal-centered d-d absorption of the ferrocenyl entity of 3, with the molar absorption
coefficient ε in the order of 102 M−1·cm−1 [47], is obscured by the MLCT band. Due to the presence
of the ferrocenyl moiety, compound 3 is not luminescent [38]. It becomes emissive after ferrocenyl
ligand dissociation.
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core [15,44]. The emission spectra measured in ethanol at ambient temperatures are broad with the 
maxima at 630 nm (Figure 3). The luminescence decay times τ found for both compounds amount to 
60 ns. The relatively short values of τ are related to efficient vibrational quenching [1] of the emissive 
3MLCT excited states of these molecules and correspond to low luminescence quantum yields of 
about 1%. Importantly, the obtained decay times measured for air-saturated solutions are almost 
equal to the τ values determined for degassed samples. This indicates a negligible influence of the 
molecular oxygen on emission quenching and enables us to use compounds 1 and 2 for confocal 
microscopy studies.  
Figure 3. Absorption and luminescence spectra of 1 in ethanol at ambient temperature.
Table 2. Photophysical data for complexes 1–3 at ambient temperature in ethanol.
Complex Absorption Maximum λabs (nm)(Molar Absorptivity ε (M−1 cm−1))
Emission Maximum
λem (nm)
Emission Decay
Time T (ns) a
1 375 (4600), 262 (27,600) 630 60
2 375 (3600), 262 (24,100) 630 60
3 375 (4400), 262 (29,000) - -
a measured for degassed solutions.
Complexes 1 and 2 display orange luminescence characteristics for the fac[Re(CO)3(phen)]
core [15,44]. The emission spectra measure in ethanol at ambient temperat res are broad with
the maxima at 630 nm (Figure 3). The luminescence d cay times τ found for both c mpounds amount
to 60 ns. The relati ely short values of τ are related to efficient vibration l quenching [1] of the emissive
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3MLCT excited states of these molecules and correspond to low luminescence quantum yields of
about 1%. Importantly, the obtained decay times measured for air-saturated solutions are almost
equal to the τ values determined for degassed samples. This indicates a negligible influence of the
molecular oxygen on emission quenching and enables us to use compounds 1 and 2 for confocal
microscopy studies.
For completeness, it is mentioned that the MLCT character of the lowest excited states is also
predicted by density-functional (DFT) calculations performed for 1 (Figure 4). Thus, HOMO of 1 is
composed mainly from a rhenium 5d orbital perturbed with contributions from the CO and axial L
ligands. LUMO represents a pi* orbital of the phen ligand.
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2.4. Confocal Microscopy Studies
Complexes 1–3 were tested as luminescent probes for in vitro confocal microscopy bioimaging in
HeLa cancer cells. All compounds under study were found in the interiors of the cells f lowing 15 min
incubation in a medium containing 200 nM of a given compound. Emission spectra recorded for the
incubated cells were compatible with the luminescence spectra of 1 and 2 recorded in solution (Figure 5).
In Figure 5A an exemplary confocal image of HeLa cells stained with 2 is reproduced. Analogous
confocal images taken for compound 1 are shown in Figure S4A in Supplementary Materials.
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Figure 5. (A) Confocal luminescence image of living HeLa cells stained with 2; (B) View of the
photocytotoxic effect of 2 on HeLa cells after prolonged laser irradiation at 405 nm. Emission
wavelengths are represented using a false color scale (right), with colors corresponding to spectral
bands (416–647 nm total range). Scale bar 10 µm.
The luminescent probe is dominantly accumulated in mitochondria, which is confirmed by the
characteristic granular staining pattern. In addition, diffuse (weak) emission stems also from cytoplasm
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and plasma membranes. The mitochondrial accumulation is further confirmed by a co-localization
experiment using 2 and a mitochondria-specific fluorescent probe MitoTracker Green® (Figure 6).Molecules 2017, 22, 809 7 of 17 
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The co-localization of 2 and MitoTracker Green® was quantified in HeLa cells by using the
Manders (MCC) and Pearson correlation coefficient (PCC) [48]. The respective correlation coefficients
were 0.83 ± 0.11 (MCC) and 0.73 ± 0.08 (PCC), both confirming the dominant localization of 2 in the
mitochondria of HeLa cells. As expected, the staining pattern of compound 1 is the same as found
for compound 2. However, accumulation of neutral complexes in mitochondria is rather surprising,
since the negative mitochondrial potential favors an uptake of positively charged species [20–23].
These considerations let us speculate that the mechanism of action for 1 and 2 involves a complex
dissociation in the cell interior to form positively charged species having affinity to the mitochondrial
membrane. This might be related to lability of the ancillary carboxylate ligands L. To verify this
hypothesis, the non-emissive complex 3, comprising a ferrocenyl substituted carboxylate ligand,
can be used. For this compound, a similar granular staining pattern was observed (Figure S4B).
This implies that the Re complex undergoes ligand dissociation yielding a phosphorescent cation
comprising the fac-[Re(CO)3(phen)+] core. Probably, complexes 1 and 2 show the same mechanism of
mitochondria staining.
To examine the role of the mitochondrial electric potential, living HeLa cells were preincubated
with the mitochondrial uncoupler carbonyl cyanide-p-trifluoromethoxyphenylhydrazone (FCCP) [49],
prior to staining with the luminophore 2. FCCP acts as a proton transporter in mitochondria, dissipating
the proton gradient across the mitochondrial membrane [49]. Depolarization of mitochondria treated
with FCCP resulted in ca. 30% loss of the compound 2 luminescence intensity, compared to the control.
However, the cellular localization of 2 in the presence and in the absence of FCCP remains the same
(Figure S5). Such a behavior can only be rationalized by a diffusion of the positively charged Re-species
from the depolarized mitochondria out to the surrounding cellular compartments. Nevertheless, a
large amount of the compound accumulated in mitochondria is not responsive to the dissipation of
mitochondrial potential. It can be surmised that they are bound to mitochondria by non-electrostatic
forces. Accumulation of 2 did not induce loss of HeLa cell viability (Figure 5A). However, prolonged
laser irradiation (405 nm, 150 µW, 3.75 J total dose) results in cell shrinkage and plasma membrane
blebbing (Figure 5B).
Thus, loss of plasma membrane integrity in the presence of 2 was investigated by using the
propidium iodide (PI) exclusion test and wide-field image cytometry [50]. Accordingly, following
illumination with 340–380 nm (35 µW) light for 360 s (12.6 J total dose), 14 ± 5% of HeLa cells lost their
viability within 2 h, as compared to 5 ± 3% in the non-illuminated control. These results demonstrate
that impairment of cell viability by accumulation of 2 is potentiated by phototoxic effects. This notion
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is compatible with production by 2 of superoxide radicals and other reactive oxygen species (ROS),
detected with a dihydroethidium (DHE) staining assay after laser irradiation (Figure 7). This assay
relies on DHE oxidation by cellular ROS. Oxidized DHE molecules become red fluorescent upon DNA
and double stranded RNA intercalation, and as such can be detected with confocal microscopy.Molecules 2017, 22, 809 8 of 17 
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Accordingly, Figure 7B shows about 2.04 ± 0.19 times more intense fluorescence in treated cells
in comparison to the control population (Figure 7A). Confocal microscopy studies revealed some
properties of assayed molecules in living cells. In order to investigate these proprieties in more detail,
we directed our attention towards proteins as potential binding-targets for compounds 1–3.
2.5. Binding to Model Proteins
In order to evaluate if the synthetized compounds coordinate to biological macromolecules in
particular proteins, and to check if the degradation of compound 3 is the result of these interactions,
we have studied the formation of potential adducts that could form upon reaction of compounds 1 or 3
with model proteins hen egg white lysozyme (HEWL) and bovine pancreatic ribonuclease (RNase A),
which have been extensively used in the past in metalation studies [51–53]. First, the stability of
the compounds in the presence of the two proteins was evaluated by registering UV-Vis absorption
spectra of the compounds, separately, as function of time (Figures S6–S8). Data indicate that in
mixed ethanol/aqueous and DMSO/aqueous solutions the compounds remain stable, with only
minor precipitation occurring after 24 h. Then, fluorescence spectra of the two compounds alone and
in the presence of HEWL were collected in mixed ethanol/aqueous solutions, upon irradiation at
375 nm, which selectively excites assayed compounds (Figure S9). Interestingly, comparison of the
spectra collected upon excitation at 375 nm reveals that ferrocenyl derivative 3 becomes emissive in
the presence of HEWL (Figure S9). To verify that this emission is due to the formation of an adduct
of 3 with the protein, electrospray ionization mass spectrometry (ESI-MS) spectra of the preformed
HEWL-compound 3 adduct were measured and the variations of the HEWL fluorescence in the
presence of compounds 1 and 3 were analyzed. To further confirm the binding of compound 3 to the
protein, surface plasmon resonance (SPR) measurements were also collected.
In particular, fluorescence spectra of HEWL in the presence of different amounts of the two
compounds, separately, upon excitation at 280 and 295 nm, were registered using samples prepared
by mixing the protein with the two compounds separately at different protein to compound ratios,
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and then dialyzing to remove the excess of the assayed compound (Figure 8). Although limited,
the observed quenching of fluorescence intensities at increased concentrations of the compounds
corroborate the formation of “Re-protein” adducts.Molecules 2017, 22, 809 9 of 17 
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3 (0.05 mg/mL in 10% ethanol), prepared by mixing the protein with increasing concentrations of
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Further indications of the binding of compound 3 to HEWL were obtained by SPR data, reported
in Figure S10, and performed on immobilized HEWL protein employing compound 3 as analyzed.
Although limited by poor water solubility of the compound that fails to reach saturated binding
conditions and to precisely estimate the dissociation constant, these experiments indicate a value of
KD at least in the high micromolar range.
The ESI-MS spectrum of the adduct formed in the reaction of HEWL and compound 3 in a 1:10
protein to compound molar ratio is reported in Figure 9. The spectrum features new peaks at a
molecular weight higher than that of the protein.
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Figure 9. Deconvoluted electrospray ionization mass spectrometry (ESI-MS) spectra of HEWL
(1 × 10−4 M) incubated for 24 h at room temperature in the presence of compound 3. Experimental
conditions: protein to metal ratio 1:10, 20 mM ammonium acetate buffer, pH 6.8.
These peaks were assigned to adducts of HEWL with [Re(CO)3(phen)]+, [Re(CO)2(phen)]+ and
[Re(CO)2]+ fragments, respectively, and suggest post-dissociative binding of 3 to HEWL molecule.
3. Experimental Section
3.1. eneral Infor ation
ll preparations were carried out using standard Schlenk techniques. Chromatographic
separations were carried out using aluminium oxide (EcoChromTM MP Biomedicals, Santa Ana, CA,
USA). THF was distilled over Na/benzophenone prior to use. Other solvents were of reagent grade
and were used without prior purification. The NMR spectra were recorded on a Bruker AV600 Kryo
(600 MHz) spectrometer (Bruker, Bremen, Germany). Chemical shifts are reported in δ (ppm) using
residual DMSO (1H δ 2.50 ppm) as references. Mass spectra were recorded using LSIMS methods on a
Finnigan T 95 ass spectro eter (Ther o Finnigan T b , Bre en, er any). IR spectra
ere recorded on a FTIR exus icolet apparatus ( icolet, adison, I, S ). icroanalyses ere
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. . he istr
Synthesis of o plexes 1–3
eneral procedure for the synthesis of fac-[ e( ) (1,10-phenantroline)L] L = heptanoic acid,
hept-6-ynoic acid and 4-(1-ferrocenyl)-butanoic acid 1, 2, 3 co plexes:
Tri ethyla ine (46 mg, 0.045 mol, 63 µL) and silver trifluoromethanesulfonate (116 mg,
0.45 mmol) were added to a stirred mixture of the acid (0.3 mmol) and fac-[Re(CO)3
(1,10-phenantroline)Cl] (220 mg, 0.45 mmol) in THF (60 mL). The reaction mixture was stirred under
argon atmosphere at 70 ◦C for 18 h (for 1 and 3) or 72 h (for 2). The solvent was evaporated to dryness
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to afford a solid which was subjected to column chromatography on deactivated Al2O3 (Al2O3/H2O
30 g: 1.25 g) with dichloromethane as eluent. Crystallization from dichloromethane/n-hexane gave
pure products.
1 yellow solid, 95% (165 mg). 1H-NMR (600 MHz, DMSO-d6): δ = 9.43 (dd, JH,H = 5.4 Hz, 1.2 Hz, 2H,
phen), 8.96 (dd, JH,H = 8.4 Hz, 1.2 Hz, 2H, phen), 8.31 (s, 2H, phen), 8.09 (dd, JH,H = 8.4 Hz, 5.4 Hz,
2H, phen), 1.45 (t, JH,H = 7.2 Hz, 2H, CH2), 0.82 (sext, JH,H = 7.2 Hz, 2H, CH2), 0.66 (t, JH,H = 7.2 Hz,
3H, CH3), 0.59–0.50 (m, 4H, CH2), 0.31 (quint, JH,H = 7.2 Hz, 2H, CH2). 13C{1H} NMR (150 MHz,
DMSO-d6): δ = 198.5, 194.7, 176.3, 154.0, 146.0, 139.4, 130.4, 127.7, 126.3, 35.9, 30.9, 27.8, 25.6, 21.8, 13.9.
LSI MS: m/z = 581 (M + H+). FTIR (KBr ν [cm−1]): 2955 (C-H), 2930 (C-H), 2854 (C-H), 2027 (Re-C≡O),
1917 (Re-C≡O), 1869 (Re-C≡O), 1622 (C=O) cm−1. Anal. Calcd. for C22H21N2O5Re: C, 45.59%; H,
3.65%; N, 4.83%. Found: C, 45.74%; H, 3.75%; N, 5.02%.
2 yellow solid, 65% (112 mg). 1H-NMR (600 MHz, DMSO-d6): δ = 9.43 (dd, JH,H = 5.1Hz, 1.2 Hz, 2H,
phen), 8.95 (dd, JH,H = 7.8 Hz, 1.2 Hz, 2H, phen), 8.03 (s, 2H, phen), 8.09 (dd, JH,H = 8.4 Hz, 5.1 Hz, 2H,
phen), 2.56 (t, JH,H = 2.4 Hz, 1H, C≡CH), 1.49–1.45 (m, 4H, CH2), 0.66 (quint, JH,H = 7.2 Hz, 2H, CH2),
0.50 (quint, JH,H = 7.2 Hz, 2H, CH2). 13C{1H} NMR (150 MHz, DMSO-d6): δ = 198.5, 194.7, 176.1, 154.1,
154.0, 146.0, 139.5, 130.4, 127.8, 126.3, 84.1, 71.0, 35.4, 27.0, 24.8, 17.2. LSI MS: m/z = 576 (M + H+). FTIR
(KBr ν [cm−1]): 2955 (C-H), 2927 (C-H), 2854 (C-H), 2119 (C≡C), 2024 (Re-C≡O), 1910 (Re-C≡O), 1866
(Re-C≡O), 1606 (C=O) cm−1. Anal. Calcd. for C22H17N2O5Re: C, 45.91%; H, 2.98%; N, 4.87%. Found:
C, 45.93%; H, 3.00%; N, 5.15%.
3 orange solid, 48% (50 mg). 1H-NMR (600 MHz, DMSO-d6): δ = 9.45 (dd, JH,H = 5.1 Hz, 1.2 Hz,
2H, phen), 8.96 (dd, JH,H = 8.1 Hz, 1.2 Hz, 2H, phen), 8.30 (s, 2H, phen), 8.10 (dd, JH,H = 8.1 Hz,
5.1 Hz, 2H, phen), 3.92 (s, 5H, C5H5), 3.87 (pt, JH,H = 1.8 Hz, 2H, C5H4), 3.53 (pt, JH,H = 1.8 Hz, 2H,
C5H4), 1.49 (t, JH,H = 7.2 Hz, 2H, CH2), 1.41 (t, JH,H = 7.8 Hz, 2H, CH2), 0.87 (quint, JH,H = 7.2 Hz, 2H,
CH2). 13C{1H} NMR (150 MHz, DMSO-d6): δ = 198.5, 194.6, 176.3, 154.0, 146.0, 139.5, 130.4, 127.8,
126.3, 88.4, 68.1, 67.4, 66.5, 35.6, 27.6, 26.7. LSI MS: m/z = 722 (M+). FTIR (KBr ν [cm−1]): 3085(C-H),
2955(C-H), 2933(C-H), 2015(Re-C≡O), 1910(Re-C≡O), 1879(Re-C≡O), 1616(C=O) cm−1. Anal. Calcd.
for C29H23N2O5ReFe: C, 48.27%; H, 3.21%; N, 3.88%. Found: C, 48.27%; H, 3.32%; N, 4.02%.
3.3. Quantum Chemical Computations
The molecular geometry of 1 was optimized using the hybrid gradient corrected correlation
functional B3LYP [54]. For C, H, N, and O the Ahlrichs split-valence basis set SVP [55] was
applied and for valence orbitals of Re the quadruple-dzeta quality atomic basis set QZVP [56] was
applied, respectively. The inner-core electrons of Re were substituted with a relativistic effective
core potential [57]. Five lowest-energy electronic transitions were calculated for the DFT optimized
ground-state geometry using the time-dependent density functional theory (TD-DFT) and applying
the same basis sets as for the geometry optimization. All computations were carried out using the
Gaussian 09 computer program package [58].
3.4. X-ray Crystallography
Good quality single-crystals of 1–3 were selected for the X-ray diffraction experiments at
T = 100(2) K. They were mounted with paratone-N oil at the MiTeGen micro-mounts. Diffraction
data were collected on the Agilent Technologies SuperNova Dual Source diffractometer with MoKα
radiation (λ = 0.71073 Å) using CrysAlis RED software (CrysAlis CCD and CrysAlis RED, Oxford
Diffraction, Oxford Diffraction Ltd.: Yarnton, UK, 2008). The analytical numerical absorption correction
using a multifaceted crystal model based on expressions derived by R.C. Clark & J.S. Reid [59] (1 and 2)
and numerical absorption correction based on gaussian integration over a multifaceted crystal model (3)
implemented in SCALE3 ABSPACK scaling algorithm, were applied [60]. The structural determination
procedure was carried out using the SHELX package [61]. The structures were solved with direct
methods and then successive least-square refinement was carried out based on the full-matrix
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least-squares method on F2 using the XLMP program [61]. All H-atoms were positioned geometrically,
with C–H equal to 0.93, 0.96 and 0.97 Å for the aromatic/methylidyne, methyl and methylene H-atoms,
respectively, and constrained to ride on their parent atoms with Uiso(H) = xUeq(C), where x = 1.2 for
the aromatic, methylidyne and methylene H-atoms, and x = 1.5 for the methyl H-atoms. The figures
for this publication were prepared using ORTEP-3 program [62].
3.5. Luminescence Measurements
UV-Vis absorption spectra were recorded with a Varian Cary 300 double beam spectrometer.
Luminescence spectra were measured for air-saturated and degassed diluted (c≈ 5× 10−5 M) solutions
in ethanol with a Horiba Jobin Yvon Fluorolog 3 steady-state fluorescence spectrometer. For decay
time measurements, a PicoQuant LDH-P-C-375 pulsed diode laser (λexc = 372 nm, pulse width 100 ps)
was applied as the excitation source. The emission signal was detected with a cooled photomultiplier
attached to a FAST ComTec, München, Germany, multichannel scalar card with a time resolution of
250 ps. Photoluminescence quantum yields φPL were determined with a Hamamatsu C9920-02 system
equipped with a Spectralon® integrating sphere.
3.6. Biology
3.6.1. Biological Imaging
Human HeLa 21.4 cells were cultured for 48 h after seeding in Petri dishes with a glass bottom
(MaTek), reaching approximately 50% confluency. The cells were grown in Dulbeco’s minimal essential
medium (DMEM) with 5% FCS, at 5% CO2 and 37 ◦C. The same medium was used to perform all
microscopy experiments. Directly before imaging, the cells were incubated with 200 nM of 1, 2 or 3
added to the imaging medium. Stock solutions of these compounds were freshly prepared in DMSO
(200 µM). Additionally, mitochondria of live cells were labelled (where indicated) with MitoTracker®
Green (Thermofisher, Poland) by incubation with 100 nM of the dye for 20 min. Alternatively, cells were
incubated with 20 µM of dihydroethidium (DHE) for 15 min, to detect production of reactive oxygen
species (ROS). Where indicated, mitochondrial electric potential was dispersed [63] by incubation
with 5 µM carbonyl cyanide-p-trifluoromethoxyphenylhydrazone (FCCP) (30 min) prior to loading
with 2. Loss of plasma membrane integrity (indicator of cell viability) was monitored using staining
of cell nuclei with propidium iodide (PI), as described before [50]. The imaging was performed by
using LSM 780 confocal system (Zeiss), equipped AxioObserver Z1 inverted microscope, 63× oil
immersion objective (NA 1.4), 405 diode laser (30 mW), 488 nm Ar laser (25 mW) a multi-anode PMT
(32 elements). Luminescence spectrum was registered from single confocal sections (pinhole set to
1 Airy unit), in 410 nm–685 nm range, with 8.5 nm spectral precision, using 405 nm (1.8%) excitation.
Where indicated, detector elements were combined into detection bands corresponding to 600–700 nm
(1, 2, 3, excitation 405 nm) and 500–550 nm (MitoTracker® Green, excitation 488 nm). The luminescence
and transmitted light images were collected with 8.4 µs pixel dwell time and pixel size of 0.176 µm.
Alternatively, the imaging was performed using Leica SP8 confocal system, equipped with a DMI6000
inverted microscope, 63× oil immersion objective (NA 1.4), 405 nm pulsed (40 MHz) diode laser
(5 mW nominal power), 488 nm Ar laser (30 mW), hybrid (HyD) and conventional (PMT) detectors.
Luminescence (1, 2, 3) was excited using the 405 laser (5%) and registered (PMT) from single confocal
sections (pinhole set to 1 Airy unit) in 600–700 nm range. Fluorescence of ethidium (product of
DHE oxidation by ROS) was excited with 488 nm light and detected in 550–585 nm range with HyD
(integration mode). The luminescence and transmitted light images were collected with the speed
of 100 lines/s and pixel size of 0.18 µm. Loss of cell viability in the presence of 2 (200 nM) was
monitored in time with image cytometry. Image registration was performed with Leica DMI6000
inverted wide-field microscope, equipped 40× dry objective (NA 0.75), 100 W metal halide arc lamp
and a 1.4 Mp CCD camera (Sony ICX 285 chip, Leica, Wetzlar, Germany). The HeLa cells were
cultured (~50% confluency) and imaged in standard 24-well plates. Transmitted light and fluorescence
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(580–630 nm range, PI) images were registered for 18 h, with 1 h frame rate. Each well corresponded
to 9 (3 × 3 tile) fields of view probed, which translated to at least 220 monitored cells. To quantify
phototoxic effects of 2, the HeLa cells were irradiated with 35 µW of UV light (340–380 nm) for 360 s
before onset of the imaging. The time (LT50) corresponding to 50% of imaged cells losing their plasma
membrane integrity (manifested by PI staining of nuclei) was quantified for the populations of control
(1720) and UV-irradiated (1930) cells, stained with 2.
3.6.2. Reaction with Model Proteins
Interactions between compounds 1 and 3 and model proteins hen egg white lysozyme (HEWL)
and bovine pancreatic ribonuclease (RNase A) were studied by collecting (1) UV-Vis absorption
spectra of the two compounds in mixed DMSO/aqueous and ethanol/aqueous solutions in the
presence of the two proteins, separately, for 24 h; (2) Intrinsic fluorescence spectra of HEWL samples
prepared by incubating the protein in the presence of the compounds at different concentrations
for 24 h at room temperature and then dialyzing to remove the unbound compound. Spectra
were registered upon excitation at 280, 295 and 375 nm; (3) electrospray ionization mass spectra
(ESI MS) of HEWL in the absence and in the presence of the two compounds, separately, upon 24 h
of incubation at room temperature; (4) surface plasmon resonance measurements of the formation
of HEWL-compound 3 system. UV-Vis absorption spectra were recorded with a Varian Cary 5000
Uv-vis-NIR spectrophotometer under the following experimental conditions: 100% ethanol, 50%
ethanol and 50% PBS pH 7.4, 10% ethanol and 90% PBS pH 7.4 in the presence and in the absence of
the two proteins. Other spectra were recorded using DMSO instead of ethanol. A Horiba Scientific
Fluoromax-4 spectrofluorometer was used to measure fluorescence spectra. Experimental details:
excitation wavelengths = 280, 295 and 375 nm; protein concentration = 0.05 mg/mL (0.0035 mM).
Spectra were collected in 10% ethanol at 20 ◦C by comparing the protein emission spectrum with that
of the metal complex under the same experimental conditions. Different protein to metal ratio were
analyzed (HEWL:complex 1:0.5, 1:1, 1:2, 1:3, 1:5, 1:8, 1:10).
ESI MS measurements were carried out using an LCQ DECA XP Ion Trap mass spectrometer
(ThermoElectron, Milan, Italy) equipped with an OPTON ESI source (operating at 4.2-kV needle voltage
and 320 ◦C) in positive mode. Multicharge spectra were deconvoluted using the BioMass program
implemented in the Bioworks 3.1 package provided by the manufacturer. In these experiments,
proteins were incubated in the presence of the two compounds for 24 h at room temperature in 1:10
protein to metal ratio, 20 mM ammonium acetate pH 6.8.
Surface Plasmon Resonance (SPR) experiments were performed at 25 ◦C on a Biacore 3000
instrument (GE Healthcare, Buckinghamshire, UK). HEWL was immobilized at 1095 RU, on a CM5
Biacore sensor chip in 10 mM sodium acetate pH 5.5, by using the EDC/NHS chemistry, with a flow
rate of 5 µL × min−1 and an injection time of 7 min. Binding assays were carried out by injecting
90 µL of analyte, at 20 µL × min−1. Experiments were carried out at Ph = 7.4 using HBS and 8% EtOH
(v/v). Solvent correction was performed. Stock solutions of compound 3 at 3.0 mM in EtOH were
freshly prepared.
3.6.3. Deposited Data
Cif files of the structure determinations were deposited at the Cambridge Crystallographic Data
Centre (CCDC numbers 1524287-1524289). These data can be obtained free of charge via www.ccdc.
cam.ac.uk/structures.
4. Conclusions
We have synthetized and fully characterized three new neutral fac-[Re(CO)3(phen)L]
compounds (1–3) with phen = 1,10-phenanthroline and L = O2C(CH2)5CH3, O2C(CH2)4C≡CH, and
O2C(CH2)3((C5H5)Fe(C5H4)). Compounds 1 and 2 display orange luminescence characteristics for
the fac[Re(CO)3(phen)]+ core, whereas 3 is not emissive due to the presence of the ferrocenyl moiety
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that quenches the emission. Confocal microscopy study reveals selective accumulation of the three
compounds in mitochondria. Emission of 3 can only be possible when ferrocene-containing ligand
dissociates from the metal to produce another species containing the luminescent fac[Re(CO)3(phen)]+
core. Thus, dissociation of the ligands from the metal is the basis of the mitochondrial accumulation
by these compounds. In particular, the following mechanism is proposed: (i) ancillary carboxylate
ligands in 1–3 dissociate inside the cell, producing luminescent fac[Re(CO)3(phen)]+ products; (ii) these
cationic species rapidly react with various cellular matrix molecules giving secondary products,
which are uptaken into the negatively charged mitochondrial membranes; (iii) follow up reactions
lead to covalent (or charge independent) mitochondria binding as confirmed by FCCP experiments.
Corroboration of this mechanism comes from in vitro studies of reactions of the compounds 1–3
with proteins, which indicate that the fac[Re(CO)3(phen)]+ entity can bind to model proteins HEWL
and RNase A. When accumulated in mitochondria, fac[Re(CO)3(phen)]+ core triggers elevated ROS
production and induces a photocytotoxic effect.
In summary, our results reveal an interesting dissociation-driven mechanism of biological activity
for neutral fac-[Re(CO)3(phen)L] compounds. We are currently looking for biologically more relevant
carboxylate ligands (L = drugs, peptides, natural products) in order to control the biological action
profile of fac-[Re(CO)3(phen)L] complexes.
Supplementary Materials: Supplementary materials are available online.
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